Director Mitarotonda James A acquired 100,000 shares in Avon Products, Inc. (NYSE:AVP) for $4,329,808 in transaction occurred on 2018/08/13. After making this transaction, the Director owns a direct stake of 169,000 shares, worth $8,573,020, as per the last closing price. On 2018/08/09 Mitarotonda James A, Director at AVP, purchased 500,000 shares at an average price of $1.82 per share. The new stake is valued at $8,375,020.

Separately, it had been reported that some other AVP insiders also took part of the insider trading activity. Director, Mitarotonda James A had invested in 456,908 shares for $3,729,778 through a trade on 2018/05/22. Following this activity, the insider holds 872,694 shares worth $7,384,960 as of recent close. Wall Street’s most bullish Avon Products, Inc. (NYSE:AVP) analysts are predicting the share price to blow past $3 per share during the next 12 months. The current median share price forecast by them is $2.5, suggesting that the stock could increase 26.26% in that time frame. The average price target of $2.36 calls for a nearly 19.19% increase in the stock price.

Avon Products, Inc. (AVP) trading activity significantly weakened as the volume at ready counter decreased to 3,338,190 shares versus 3,498,555 in average daily trading volume over the past 20 days. So far this year, the volume has averaged about 5,067,339 shares. The share price dropped -3.88% in recent trade and currently has a stock-market value of $900.62M. The shares finished at $1.98, after trading as low as $1.97 earlier in the session. It hit an intraday high Thursday at $2.07. The stock is now 43.48% above against its bear-market low of $1.38 on July 20, 2018. It has retreated -51.01% since it’s 52-week high of $2.99 reached in April. Now the market price is down -3.41% on the year and down -7.91% YTD.

AVP’s 50 day simple moving average (SMA 50) price is $2.01 and its 200-day simple moving average (SMA 200) price is $2.09. The company’s stock currently has a total float of 440.08M shares. Its weekly volatility is hovering around 5.92% and felt 5.28% volatility in price over a month. On the upside, the share price will test short term resistance at around $2.04. On a downside, the stock is likely to find some support, which begins at $1.94. The failure to get near-term support could push it to $1.91.

It had seen a positive analyst call from Jefferies, which upgraded the stock from Underperform to Hold on July 18. Analysts at BofA/Merrill, shed their positive views on January 04 by lowering it fromNeutral to Underperform. Analysts at Jefferies, made their first call about the stock on September 13, recommending it is Underperform. UBS, reiterated their call for Sell, on August 04. On the other hand, they had set new target price to $2.75 versus $3.50.

When looking at valuations, Avon Products, Inc. (AVP) has a cheap P/E of 7.44x as compared to industry average of 59.39x. Moreover, it trades for 14.67 times the next 12 months of expected earnings. Compared to others, Avon Products, Inc. is in a different league with regards to profitability, having net margins of 0.1%. To put some perspective around this, the industry’s average net margin is 10.16%. AVP’s ROE is -0.8%, which is also considerably worse than the industry’s ROE of 15.28%. It’s also very liquid in the near term, with a current ratio of 1.3. The stock has a debt/capital of 0.

Shares of Avon Products, Inc. (AVP) have gained 5.1% since the company’s last earnings report. Over the past 12 fiscal quarters, Avon Products, Inc. (NYSE:AVP) has topped consensus earnings estimates in 2 quarters (16%), missed earnings in 9 quarters (75%), whereas at 1 occasion EPS met analyst expectations. AVP last reported earnings on November 01, 2018 when it released Sep-18 results that receded expectations. The company raked in 0 per share, -100% change on the same period last year. That was worse than consensus for $0.01. Revenue for the recent quarter stood at $1.26 billion, down -11% on last year and below the $1.32 billion predicted by analysts. For this quarter, Wall Street analysts forecast revenue in a range of $1.39 billion to $1.52 billion, which should be compared with $1.61 billion generated last year. EPS is seen in a range of $0.05 to $0.12, against the $0.11 reported a year ago.